Successful inguinal interstitial brachytherapy in metastatic cervical carcinoma: a case report

• DOI: 10.3389/fonc.2023.1330681
• Publication Date: 2024-01-15T04:29:25Z
• Authors: Yi Qin; Ping Guan; Dan Li; Huailin He; Wenfeng He; Longjing Tan; Xiangyu Deng; Bizhen Liao; Qinglian Wen; Zhenhua Zhang
• Keywords: Multimodal therapy; Cervical lymph nodes; Metastatic carcinoma; Systemic therapy

Background Treatment of metastatic cervical cancer is a tricky issue. Currently, the National Comprehensive Cancer Network (NCCN) guideline recommends chemotherapy combined with bevacizumab for recurrent or cancer. Still, recurrence rate high and survival low after standard treatment. We urgently need to achieve multimodal therapy approach Case description report case patient stage IB2 squamous carcinoma who developed multiple metastases within short term receiving first-line treatment, she underwent interstitial brachytherapy systemic an encouraging outcome. The suspected inguinal lymph node 9 months at end in nodes, anterior abdominal wall, right lung 17 months. As had residual nodes therapy, received 3D-printed template-guided maintenance therapy. By Sep 2023, achieved good treatment outcome progression-free (PFS) 36 Conclusion Based on our response, when develop early-stage we may consider implementing local